Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
IndustryJune 23, 2026

Ibogaine Gains Attention as SUD Treatment Option Despite Safety Concerns

Providers are increasingly encountering patients interested in ibogaine, a psychoactive substance being explored for substance use disorder treatment. While ibogaine remains unregulated in the United States and carries cardiac risks, some patients are pursuing treatment domestically or traveling abroad to access it. The article urges providers to understand ibogaine's risks and benefits rather than dismiss it outright, as patient interest continues to grow. No immediate regulatory or policy changes are described.

Why it mattersMedicaid managed care organizations may see members inquiring about or seeking ibogaine treatment for substance use disorder, requiring medical directors to develop clinical guidance and care coordination protocols for this emerging but high-risk intervention.

Behavioral Health

Read the full article at medcitynews.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.